[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361189-105":59,"doc-detail-361189-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","personalizing-adjuvant-radiotherapy-decisions-in-breast-cancer-an-externally-test-mri-radiomics-approach-for-recurrence-risk-stratification","Personalizing adjuvant radiotherapy decisions in breast cancer - an externally test MRI radiomics approach for recurrence risk stratification","","Purpose-driven study building a preoperative MRI-based radiomics signature to estimate recurrence-free survival and determine which breast cancer patients benefit from adjuvant radiotherapy. Two independent centers provided 771 eligible patients: 504 for training from Yunnan Cancer Hospital and 267 as an external test from the Duke Breast Cancer MRI Study. Radiomics features formed a Rad-score using correlation and clustering, combined with independent clinicopathological risks into a nomogram. Discrimination, calibration, and clinical utility were evaluated, and Kaplan–Meier analysis assessed radiotherapy benefit. Results show worse RFS for the high-risk group and significant radiotherapy association with RFS in the low-risk group.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/personalizing-adjuvant-radiotherapy-decisions-in-breast-cancer-an-externally-test-mri-radiomics-approach-for-recurrence-risk-stratification/361189/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/personalizing-adjuvant-radiotherapy-decisions-in-breast-cancer-an-externally-test-mri-radiomics-approach-for-recurrence-risk-stratification/361189.png","ImageObject",300,407,{"name":92,"@type":93},"PakDamar76","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of the MRI radiomics approach in this study?","Question",{"text":112,"@type":113},"To develop a radiomics signature based on preoperative MRI that predicts recurrence-free survival and identifies which breast cancer patients are likely to benefit from adjuvant radiotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients selected and split into training and external test sets?",{"text":117,"@type":113},"A total of 771 eligible patients from two independent centers were included: 504 patients formed the training set from Yunnan Cancer Hospital, and 267 patients formed an external test set from the Duke Breast Cancer MRI Study.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the results suggest about adjuvant radiotherapy benefit for different risk groups?",{"text":121,"@type":113},"High-risk patients showed no significant association between adjuvant radiotherapy and outcomes, while low-risk patients had a significant association with improved recurrence-free survival in both training and external test sets.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361189,1790532823,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Long etal. Radiation Oncology (2026) 21:106 Radiation Oncology  \n[https://doi.org/10.1186/s13014-026-02868-z](https://doi.org/10.1186/s13014-026-02868-z)  \nRESEARCH Open Access  \nPersonalizing adjuvant radiotherapy decisions in breast cancer: an externally test MRI radiomics approach for recurrence risk stratification  \nMan Long1†, Yu Xie1†, Jinqiu Ruan2†, Rui Liao3†, Xia Zheng1, Songliang Gao1, Keyu Mao1, Guili Dong1, Guangjun Yang1*, Zhuolin Li 1* and Zhenhui Li 1*  \nAbstract  \nPurpose To develop a radiomics signature based on preoperative MRI to predict recurrence-free survival (RFS) and which patients will benefit from adjuvant radiotherapy in breast cancer patients.  \nExperimental design 771 eligible patients from two independent centers were collected. The training set (n = 504) obtained was from the Yunnan Cancer Hospital, and the external test set (n = 267) was obtained from the Duke Breast Cancer MRI Study. Pearson correlation analysis and clustering were used to construct the radiomics signature Rad-score. Based on the best cut-off value, the patients were divided into a high-risk group and a low-risk group, and the prognostic value was evaluated. A combined model nomogram was developed based on the radiomics features incorporating independent clinicopathological risk factors. The combined model’s performance was assessed regarding its discrimination, calibration, and clinical usefulness. Kaplan-Meier analysis was used to identify patients who benefited from adjuvant radiotherapy.  \nResults The high-risk group was significantly associated with worse RFS in the training and test sets (p = 0.001 and 0. 048) . The combination model can accurately predict BC recurrence risk (AUC, 0 . 752; 95% confidence interval [CI], 0 .698–0. 807) . Additionally, adjuvant radiotherapy was not associated with the outcome of high-risk patients (training and test sets: p = 0.665 and 0 . 903, respectively) . In the low-risk group, adjuvant radiotherapy was significantly  \nassociated with RFS (training and test sets: p = 0.004 and P＜0 . 001) .  \nConclusions The Rad-score can effectively predict the prognosis of patients with breast cancer, and identify high-risk patients who do not benefit from adjuvant radiotherapy.  \n†Man Long, Yu Xie, Jinqiu Ruan, and Rui Liao Joint first authors.  \n*Correspondence: Guangjun Yang [ygj350493684@163.com](ygj350493684@163.com)[ ](ygj350493684@163.com)Zhuolin Li[lizhuolin0327@163.com](lizhuolin0327@163.com)[ ](lizhuolin0327@163.com)Zhenhui Li[lizhenhui@Kmmu.edu.cn](lizhenhui@Kmmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLong et al. Radiation Oncology (2026) 21:106 Page 2 of 13  \nClinical trial number Not applicable.  \nKeywords Breast cancer, Radiomics, Magnetic resonance imaging, Breast-conserving surgery, Radical mastectomy  \nIntroduction  \nB","cbCaitjVaFZzZB2I","https://ap.wps.com/l/cbCaitjVaFZzZB2I","pdf",2743978,13,"English","# Abstract\n# Introduction\n## Background and clinical need\n## Limits of conventional prognostic approaches\n## Role of AI and radiomics","[{\"question\":\"What is the purpose of the MRI radiomics approach in this study?\",\"answer\":\"To develop a radiomics signature based on preoperative MRI that predicts recurrence-free survival and identifies which breast cancer patients are likely to benefit from adjuvant radiotherapy.\"},{\"question\":\"How were patients selected and split into training and external test sets?\",\"answer\":\"A total of 771 eligible patients from two independent centers were included: 504 patients formed the training set from Yunnan Cancer Hospital, and 267 patients formed an external test set from the Duke Breast Cancer MRI Study.\"},{\"question\":\"What do the results suggest about adjuvant radiotherapy benefit for different risk groups?\",\"answer\":\"High-risk patients showed no significant association between adjuvant radiotherapy and outcomes, while low-risk patients had a significant association with improved recurrence-free survival in both training and external test sets.\"}]","Personalizing adjuvant radiotherapy decisions in breast cancer - an externally test MRI radiomics approach for recurrence risk stratification | PDF",1790143458,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ba61da182eedaf5fed9798f30210c27.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bff1233a0388514e32da35c96b25624.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40ba5a7dd2048015fcd2c47cf7d3f5c3.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18c4170d59f987de42009cb2016524f1.webp",980,1306]